Literature DB >> 32880761

Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan.

Takahito Moriyama1, Hiroshi Kataoka2, Kosaku Nitta2, Keita Hirano3,4, Keiichi Matsuzaki5,6, Takashi Yasuda7, Yoshinari Yasuda8, Kentaro Koike4, Shoichi Maruyama8, Takashi Yokoo4, Seiichi Matsuo8, Tetsuya Kawamura4, Yusuke Suzuki5.   

Abstract

BACKGROUND: Steroid pulse therapy with tonsillectomy is known as a major treatment for IgA nephropathy (IgAN). However, its protocol was different among institutions and the effects of varying the number of steroid pulses remain unclear.
METHODS: From a total of 1,174 IgAN patients in a multicenter retrospective cohort analysis in Japan, 195 patients were treated by tonsillectomy combined with corticosteroid. They were divided into four groups based on the number of administered steroid pulses from 0 to three (TSP0-3), and remission of urinary abnormalities and renal survival until 1.5-fold increase in serum creatinine level from baseline were analyzed among the four groups and between TSP1 and TSP3.
RESULTS: Among the four groups, renal function was relatively good when the estimated glomerular filtration rate was approximately 80-90 mL/min/1.73m2 and proteinuria was relatively mild (< 1.0 g/gCre). The ratio of patients who developed renal dysfunction was < 5% in all groups, and the cumulative renal survival rate by Kaplan-Meier analysis was similar among groups (log-rank test, p = 0.37), despite varying clinical backgrounds and treatments. After adjustment of the background variables between TSP1 and TSP3, the remission rates of urinary abnormalities were similar and the renal survival rate also remained similar (66.8 vs. 85.4%, p = 0.45).
CONCLUSIONS: In patients with mild proteinuria and good renal function, the number of steroid pulses did not affect the renal outcome in steroid pulse therapy with tonsillectomy. The adaptation and protocols, such as the number of steroid pulses, should be determined for each IgAN patient's background.

Entities:  

Keywords:  IgA nephropathy; Prognosis; Steroid pulse therapy; Tonsillectomy

Year:  2020        PMID: 32880761     DOI: 10.1007/s10157-020-01960-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  34 in total

1.  Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.

Authors:  O Hotta; M Miyazaki; T Furuta; S Tomioka; S Chiba; I Horigome; K Abe; Y Taguma
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

2.  Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy.

Authors:  Ayami Ochi; Takahito Moriyama; Takashi Takei; Keiko Uchida; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2012-07-26       Impact factor: 2.370

3.  Retrospective comparison of the efficacy of tonsillectomy with and without steroid-pulse therapy in IgA nephropathy patients.

Authors:  Naoki Nakagawa; Maki Kabara; Motoki Matsuki; Junko Chinda; Takayuki Fujino; Tomoya Hirayama; Miki Takahara; Yasuaki Harabuchi; Kenjiro Kikuchi; Naoyuki Hasebe
Journal:  Intern Med       Date:  2012-06-01       Impact factor: 1.271

4.  Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy.

Authors:  Naoto Miura; Hirokazu Imai; Shogo Kikuchi; Shogo Hayashi; Masayuki Endoh; Tetsuya Kawamura; Yasuhiko Tomino; Kumiko Moriwaki; Hideyasu Kiyomoto; Kentaro Kohagura; Eiko Nakazawa; Eiji Kusano; Toshio Mochizuki; Shinsuke Nomura; Tamaki Sasaki; Naoki Kashihara; Jun Soma; Tadashi Tomo; Iwao Nakabayashi; Masaharu Yoshida; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

5.  Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy.

Authors:  Mitsuhiro Sato; Osamu Hotta; Sachiko Tomioka; Ikuo Horigome; Shigemi Chiba; Mariko Miyazaki; Hiroo Noshiro; Yoshio Taguma
Journal:  Nephron Clin Pract       Date:  2003

6.  Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study.

Authors:  Hiroyuki Komatsu; Shouichi Fujimoto; Seiichiro Hara; Yuji Sato; Kazuhiro Yamada; Kazuo Kitamura
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-28       Impact factor: 8.237

7.  Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.

Authors:  Masaki Ohya; Haruhisa Otani; Yoshinobu Minami; Shintaro Yamanaka; Toru Mima; Shigeo Negi; Susumu Yukawa; Takashi Shigematsu
Journal:  Clin Nephrol       Date:  2013-07       Impact factor: 0.975

8.  Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathy.

Authors:  Yoshihiro Yamamoto; Yoshiyuki Hiki; Shigeru Nakai; Koichiro Yamamoto; Kazuo Takahashi; Shigehisa Koide; Kazutaka Murakami; Makoto Tomita; Midori Hasegawa; Shiro Kawashima; Satoshi Sugiyama; Yukio Yuzawa
Journal:  Clin Exp Nephrol       Date:  2012-08-29       Impact factor: 2.801

9.  Nationwide survey on current treatments for IgA nephropathy in Japan.

Authors:  Keiichi Matsuzaki; Yusuke Suzuki; Junichiro Nakata; Naoko Sakamoto; Satoshi Horikoshi; Tetsuya Kawamura; Seiichi Matsuo; Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2013-03-22       Impact factor: 2.801

10.  A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy.

Authors:  Tetsuya Kawamura; Mitsuhiro Yoshimura; Yoichi Miyazaki; Hidekazu Okamoto; Kenjiro Kimura; Keita Hirano; Masato Matsushima; Yasunori Utsunomiya; Makoto Ogura; Takashi Yokoo; Hideo Okonogi; Takeo Ishii; Akihiko Hamaguchi; Hiroyuki Ueda; Akira Furusu; Satoshi Horikoshi; Yusuke Suzuki; Takanori Shibata; Takashi Yasuda; Sayuri Shirai; Toshiyuki Imasawa; Koichi Kanozawa; Akira Wada; Izumi Yamaji; Naoto Miura; Hirokazu Imai; Kenji Kasai; Jun Soma; Shouichi Fujimoto; Seiichi Matsuo; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2014-03-03       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.